Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2025 Earnings Call Transcript November 6, 2025
Collegium Pharmaceutical, Inc. beats earnings expectations. Reported EPS is $2.25, expectations were $1.88.
Operator: Greetings, and welcome to the Collegium Pharmaceuticals Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the call over to Ian Karp, Head of Investor Relations at Collegium. Thank you. You...
